Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1962 2
1964 3
1965 4
1966 8
1967 1
1968 5
1969 4
1970 8
1971 1
1972 4
1973 3
1974 5
1975 1
1976 1
1977 3
1978 5
1979 1
1980 5
1981 6
1982 8
1983 6
1984 6
1985 4
1986 5
1987 6
1988 8
1989 10
1990 9
1991 5
1992 11
1993 8
1994 4
1995 11
1996 8
1997 10
1998 4
1999 5
2000 7
2001 2
2002 4
2003 6
2004 6
2005 17
2006 15
2007 12
2008 12
2009 13
2010 13
2011 18
2012 25
2013 26
2014 19
2015 22
2016 21
2017 22
2018 16
2019 22
2020 16
2021 19
2022 25
2023 17
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Results by year

Filters applied: . Clear all
Page 1
The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. Terziroli Beretta-Piccoli B, et al. Among authors: shimoda s. J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20. J Autoimmun. 2019. PMID: 31548157 Review.
Liver architecture, cell function, and disease.
Ishibashi H, Nakamura M, Komori A, Migita K, Shimoda S. Ishibashi H, et al. Among authors: shimoda s. Semin Immunopathol. 2009 Sep;31(3):399-409. doi: 10.1007/s00281-009-0155-6. Epub 2009 May 26. Semin Immunopathol. 2009. PMID: 19468732 Review.
[New strategies in anti-tumor immunotherapy].
Iga-Murahashi M, Hijikata Y, Suehiro Y, Inoue H, Tanaka Y, Shimoda S, Marumoto T, Okazai T, Yoshida K, Tsunoda T, Tani K. Iga-Murahashi M, et al. Among authors: shimoda s. Rinsho Ketsueki. 2010 Nov;51(11):1654-60. Rinsho Ketsueki. 2010. PMID: 21157128 Review. Japanese. No abstract available.
The immune response to mitochondrial autoantigens.
Ishibashi H, Shimoda S, Gershwin ME. Ishibashi H, et al. Among authors: shimoda s. Semin Liver Dis. 2005 Aug;25(3):337-46. doi: 10.1055/s-2005-916325. Semin Liver Dis. 2005. PMID: 16143949 Review.
T cell immunity in autoimmune hepatitis.
Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. Ichiki Y, et al. Among authors: shimoda s. Autoimmun Rev. 2005 Jun;4(5):315-21. doi: 10.1016/j.autrev.2005.01.005. Epub 2005 Feb 15. Autoimmun Rev. 2005. PMID: 15990080 Review.
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Ogawa E, Nakamuta M, Koyanagi T, Ooho A, Furusyo N, Kajiwara E, Dohmen K, Kawano A, Satoh T, Takahashi K, Azuma K, Yamashita N, Yamashita N, Sugimoto R, Amagase H, Kuniyoshi M, Ichiki Y, Morita C, Kato M, Shimoda S, Nomura H, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Ogawa E, et al. Among authors: shimoda s. Aliment Pharmacol Ther. 2022 Aug;56(4):713-722. doi: 10.1111/apt.17107. Epub 2022 Jun 23. Aliment Pharmacol Ther. 2022. PMID: 35735794 Free PMC article.
T cell immunity and primary biliary cirrhosis.
Ishibashi H, Nakamura M, Shimoda S, Gershwin ME. Ishibashi H, et al. Among authors: shimoda s. Autoimmun Rev. 2003 Jan;2(1):19-24. doi: 10.1016/s1568-9972(02)00122-2. Autoimmun Rev. 2003. PMID: 12848971 Review.
527 results